卫光生物：关于收到药品注册临床试验受理通知书的公告

Core Viewpoint - Shenzhen Weiguang Biological Products Co., Ltd. has received the acceptance notice for the clinical trial application of subcutaneous human immunoglobulin production from the National Medical Products Administration [2] Group 1 - The company announced the receipt of the clinical trial application acceptance notice on December 24 [2] - The clinical trial is for domestically produced subcutaneous human immunoglobulin [2]